CDC’s Rapid Response Helps Solve First Infant Botulism Outbreak Linked to Formula

Translate to Spanish or other 102 languages!

The Centers for Disease Control and Prevention (CDC) released an update on the ongoing investigation of infant botulism cases linked to ByHeart infant formula. Image for illustration purposes
The Centers for Disease Control and Prevention (CDC) released an update on the ongoing investigation of infant botulism cases linked to ByHeart infant formula. Image for illustration purposes
- Advertisement -

ATLANTA – The Centers for Disease Control and Prevention (CDC) released an update on the ongoing investigation of infant botulism cases linked to ByHeart infant formula. After assessing previously reported infant botulism cases in collaboration with the California Department of Public Health’s Infant Botulism Treatment and Prevention Program (IBTPP), CDC investigators expanded the outbreak date range to include 10 cases dating back to December 2023. 

As of December 10, 2025, a total of 51 sick infants from 19 states have been hospitalized and treated with BabyBIG® in this outbreak. No deaths have been reported. Infant botulism happens when a baby swallows Clostridium botulinum spores that grow in the gut and make toxin. Infant botulism often starts with constipation but is usually first noticed as difficulty feeding (sucking and swallowing), a weak and altered cry, and lack of head control.

CDC continues to urge parents to stop using any ByHeart Whole Nutrition infant formula immediately, even if it is mistakenly found for sale in stores or online. Laboratory tests have shown that the formula is contaminated with botulism spores and can make infants sick. 

- Advertisement -

This investigation is an outstanding example of CDC’s ability to rapidly respond to threats to Americans’ health and safety. On November 7, 2025, CDC was notified by IBTPP of a concerning increase in infant botulism, typically a rare illness, in infants consuming ByHeart infant formula. “While we typically expect to see 150-180 individual cases of infant botulism annually, an outbreak of infant botulism is unprecedented,” says Dr. Jennifer Cope, the chief of the Enteric Diseases Epidemiology Branch. That evening, CDC and the U.S. Food and Drug Administration were already on the phone with ByHeart urging swift action to remove some of their formula from the market. The next day, November 8, CDC urged all parents in America to stop using two lots of ByHeart formula and informed them of the outbreak. 

The outbreak team continued to evaluate data in real time, and by November 11, CDC expanded its warning to immediately stop using any ByHeart infant formula. CDC laboratories are testing clinical samples from sick infants and samples from open containers of ByHeart infant formula collected from homes of sick infants. 

Although this is the first ever outbreak of infant botulism, CDC experts used their rapid response skillset to act immediately to save the lives of infants in America and provide clear guidance to frightened parents during a health emergency.

Information source: CDC

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Why Strength Training Is Your Best Defense Against Osteoporosis

Reports show women are at higher risk for developing the bone weakening condition as they get older.

Social Security Administration Corrects Millions of Records in Major Database Cleanup

The Social Security Administration (SSA) announced on October 20, 2026, that it has corrected millions of Social Security number records in what the agency describes as its most comprehensive record-integrity initiative in 91 years.

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

A UTHealth Houston Physician Turned a Texas Teen’s Frightening Diagnosis into a Champion Title

Two years ago, Geordon Boulware, now 15, was at a routine dental visit in his hometown of Lufkin, Texas, when his dentist discovered he had an abnormal growth on his jaw. After meeting with a local oral surgeon, Geordon and his mom decided to seek treatment in Houston. 
- Advertisement -